- Home
- PMAX vs NUWE Comparison
PMAX vs NUWE Comparison
Compare PMAX & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMAX | NUWE |
|---|---|---|
| Founded | 2019 | 1999 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2M | 3.2M |
| IPO Year | 2024 | 2012 |
Fundamental Metrics
Financial Performance| Metric | PMAX | NUWE |
|---|---|---|
| Price | $0.75 | $5.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 863.7K | ★ 1.4M |
| Earning Date | 11-24-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,270,000.00 |
| Revenue This Year | N/A | $19.32 |
| Revenue Next Year | N/A | $12.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.20 | $0.28 |
| 52 Week High | $4.81 | $222.30 |
Technical Indicators
Market Signals| Indicator | PMAX | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 49.60 |
| Support Level | $0.24 | $3.85 |
| Resistance Level | $1.09 | $7.15 |
| Average True Range (ATR) | 0.12 | 0.80 |
| MACD | 0.04 | 0.31 |
| Stochastic Oscillator | 46.27 | 76.71 |
Price Performance
Historical ComparisonAbout PMAX Powell Max Limited
Powell Max Ltd operates as a financial communications platform supporting listed companies and IPO applicants throughout the capital markets lifecycle. Substantially all of the company's revenue is generated from Hong Kong. The group focused on supporting the disclosure, reporting, and transaction needs of corporate clients and their advisors. Its mission is to combine industry knowledge, execution capabilities, and a commitment to service to deliver accurate, timely, and reliable solutions for customers.
About NUWE Nuwellis Inc.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.